New Delhi: Eminent Indian virologist, Gagandeep Kang is skeptical about the Centre’s claim that it will get over 2 billion doses of vaccine from August to December. The production capacity of vaccine makers such as Serum Institute and Bharat Biotech is yet to ramp up, she said.
There is also no sufficient data to show the efficacy of Bharat Biotech’s nasal vaccine and Zydus Cadila’s DNA vaccine, she told Moneycontrol in an exclusive interview.
“I take the projections with a grain of salt. If you remember, last year, we were told that, by December, Serum Institute would produce 100 million doses of vaccine and Bharat Biotech in tens of millions of doses. There was going to be a large stockpile that was available with them. As we have found, that is not the case,” Kang told Moneycontrol.
It may be recalled that some states have floated global tenders for procuring a total of 121 million vaccine doses.
Berhampur: A stone weighing 2 kg fell from the ‘Singhadwara Gumuta’ of the Lord Jagannath…
New Delhi: Recent pictures of Space Station Commander Sunita Williams from the International Space Station…
Mumbai: Actress Rupali Ganguly recently filed a Rs 50 crore defamation case against her stepdaughter…
Chennai: Odisha will face Manipur in the semifinals of the 14th Hockey India Senior Men’s…
New Delhi: India will again ask Canada for the extradition of designated Khalistani terrorist Arshdeep Singh…
Berhampur: Police have arrested a man from West Bengal for allegedly claiming himself to be…
Mumbai: Carving a niche for himself in Bollywood was not a cakewalk for ‘The Family…
Mumbai: Mukesh Khanna’s Indian superhero series ‘Shaktimaan’ has been making headlines for quite some time…